{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:40:08Z","timestamp":1748972408024,"version":"3.41.0"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1097\/ftd.0000000000001193","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:00:41Z","timestamp":1711512041000},"page":"553-555","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Monitoring of Tissue and Plasma Imipenem Concentrations for the Treatment of Necrotizing Fasciitis With Carbapenem-Resistant Enterobacteriaceae\u2014A Letter to the Editor"],"prefix":"10.1097","volume":"46","author":[{"given":"Antonin","family":"Dufraigne","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Intensive et R\u00e9animation G, CHU de Saint-Etienne, Saint-Etienne, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Perinel-Ragey","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive et R\u00e9animation G, CHU de Saint-Etienne, Saint-Etienne, France;"},{"name":"SAINBIOSE U1059 Research Unit, Universit\u00e9 Jean Monnet, INSERM, Saint-Etienne, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Guitton","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et Toxicologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-B\u00e9nite, France;"},{"name":"Laboratoire de Toxicologie, ISPB, Facult\u00e9 de Pharmacie, Universit\u00e9 Lyon 1, Universit\u00e9 de Lyon, Lyon, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Cohen","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et Toxicologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-B\u00e9nite, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Thiery","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive et R\u00e9animation G, CHU de Saint-Etienne, Saint-Etienne, France;"},{"name":"Research on Healthcare Performance RESHAPE, INSERM U1290, Universit\u00e9 Claude Bernard Lyon, Villeurbanne, France; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3113-7301","authenticated-orcid":false,"given":"Manon","family":"Launay","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive et R\u00e9animation G, CHU de Saint-Etienne, Saint-Etienne, France;"},{"name":"Centre r\u00e9gional de pharmacovigilance, CHU de Saint-Etienne, Saint Etienne, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","article-title":"Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Soci\u00e9t\u00e9 Fran\u00e7aise d'Anesth\u00e9sie et R\u00e9animation-SFAR)","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/00003495-200767070-00006","article-title":"Comparative review of the carbapenems","volume":"67","author":"Zhanel","year":"2007","journal-title":"Drugs"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/AAC.01595-08","article-title":"High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function","volume":"54","author":"Lamoth","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-20250603","first-page":"ejhpharm-2022-003403","article-title":"Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients","author":"Bai","year":"2023","journal-title":"Eur J Hosp Pharm"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mcp.2002.122526","article-title":"Tissue distribution of imipenem in critically ill patients","volume":"71","author":"Tegeder","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","article-title":"The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients","volume":"50","author":"Ulldemolins","year":"2011","journal-title":"Clin Pharmacokinet"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:16:15Z","timestamp":1748970975000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001193","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}